Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.19.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Allowance for accounts receivable, net $ 1,834 $ 1,841
Deferred financing costs, net $ 0 $ 0
Preferred shares, par value (USD per share) $ 0.01 $ 0.01
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Preferred stock outstanding (shares) 0 0
Common shares, par value (USD per share) $ 0.01 $ 0.01
Common stock authorized (shares) 150,000,000 150,000,000
Common stock issued (shares) 34,382,599 33,869,589
Common stock outstanding (shares) 33,869,569 33,869,589
Common treasury stock (shares) 513,010 232,892